Trump's top pick to lead Medicare, Dr. Mehmet Oz, has a glaring conflict of interest: that he was sponsored by the company ...
More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...
On Nov. 26, the Biden administration announced a plan to require Medicare and Medicaid to cover weight loss medications like ...
The Federal Trade Commission requires influencers to disclose when a post is a paid advertisement — and a public interest ...
West Virginia’s Public Employee Insurance Agency (PEIA) is in a bind. Medical inflation continues to drive up health care costs and the PEIA finance board is looking for ways to save money while ...
Though some doctors have been trying to classify “obesity” as a “chronic illness,” being fat and being ill aren’t the same ...
A new rule the Biden administration has proposed that would let Americans with Medicare and Medicaid access Ozempic, Wegovy ...